Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therapies into healthcare systems. In this interview, he reflects on the policy landscape, regulatory challenges, and the future of access to these emerging treatments in the EU.

With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovbakh, Chair of the Civil Society Forum on Drugs, about what the strategy means in practice and the role of civil society moving forward.

As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and István Gábor Takács reflect on decades of activism—and explain why they are now taking their fight to the streets to challenge an increasingly repressive system.

After 15 years at the helm of the International Drug Policy Consortium, Ann Fordham is stepping down as Executive Director. Under her leadership, IDPC has grown into one of the most influential global networks advocating for drug policies grounded in human rights, public health, and social justice. In this interview, we reflect on IDPC’s achievements, ongoing challenges, and what lies ahead.

Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.

Leor Roseman is a psychedelic researcher whose work explores both the individual and collective dimensions of psychedelic experience — from DMT interruption studies to intergroup healing in the Israeli-Palestinian context. In this interview, we discuss how psychedelics may open space not only for personal transformation, but also for collective reconciliation.

Psychedelic therapy can offer spiritual validation and gender euphoria for trans and non-binary people — Jae Sevelius explains what truly affirming psychedelic care means in practice.

Clinical psychologist Brian Richards, Psy.D., explains how psychedelics can transform palliative care—from creating truly healing therapeutic spaces to supporting patients facing the end of life.

Two spiritual leaders from different faiths reveal how psychedelics are transforming their understanding of religion, community, and each other — watch Drugreporter’s new interview!

In Drugreporter’s new interview, trauma expert Bessel van der Kolk, MD explores how the body stores trauma and why integration is essential for healing in psychedelic therapy.